Cargando…

FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation

Few studies implicate immunoregulatory gene expression in tumor cells in arbitrating brain tumor progression. Here we show that fibrinogen-like protein 2 (FGL2) is highly expressed in glioma stem cells and primary glioblastoma (GBM) cells. FGL2 knockout in tumor cells did not affect tumor-cell proli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Jun, Zhao, Qingnan, Gabrusiewicz, Konrad, Kong, Ling-Yuan, Xia, Xueqing, Wang, Jian, Ott, Martina, Xu, Jingda, Davis, R. Eric, Huo, Longfei, Rao, Ganesh, Sun, Shao-Cong, Watowich, Stephanie S., Heimberger, Amy B., Li, Shulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347641/ https://www.ncbi.nlm.nih.gov/pubmed/30683885 http://dx.doi.org/10.1038/s41467-018-08271-x

Ejemplares similares

Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019)

FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells
por: Zhao, Qingnan, et al.
Publicado: (2023)

Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells
por: Noh, Hyangsoon, et al.
Publicado: (2016)

The Controversial Role of Microglia in Malignant Gliomas
por: Wei, Jun, et al.
Publicado: (2013)

Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103(+) conventional dendritic cells
por: Zhou, Yifan, et al.
Publicado: (2020)

Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
por: Hu, Jiemiao, et al.
Publicado: (2021)

Fgl2: link between hepatitis B and SARS?
por: Robertson, Morag
Publicado: (2003)

Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
por: Tang, Xi-Yang, et al.
Publicado: (2022)

The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection
por: Shalev, Itay, et al.
Publicado: (2010)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

Dynamics of Functionally Graded Laminated (FGL) Media—Theoretical Tolerance Modelling
por: Jędrysiak, Jarosław
Publicado: (2023)

Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
por: Qian, Wenjing, et al.
Publicado: (2021)

sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis
por: An, Tianhui, et al.
Publicado: (2023)

MLTI-01. IMMUNOLOGICAL REPROGRAMMING IN THE CNS TUMOR MICROENVIRONMENT AND THERAPEUTIC EFFICACY OF RADIOTHERAPY WITH STAT3 BLOCKADE
por: Ott, Martina, et al.
Publicado: (2019)

miR-138 exerts anti-glioma efficacy by targeting immune checkpoints
por: Wei, Jun, et al.
Publicado: (2013)

Diversification of dendritic cell subsets: Emerging roles for STAT proteins
por: Li, Haiyan S, et al.
Publicado: (2013)

Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
por: Najem, Hinda, et al.
Publicado: (2021)

FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
por: Yuan, Kai, et al.
Publicado: (2020)

FGL-GAN: Global-Local Mask Generative Adversarial Network for Flame Image Composition
por: Qin, Kui, et al.
Publicado: (2022)

The Role of CD103(+) Dendritic Cells in the Intestinal Mucosal Immune System
por: Ruane, Darren Thomas, et al.
Publicado: (2011)

STAT3 Inhibits CD103(+) cDC1 Vaccine Efficacy in Murine Breast Cancer
por: Chrisikos, Taylor T., et al.
Publicado: (2020)

Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation
por: Liu, Xin-guang, et al.
Publicado: (2016)

Abnormal Expression of the LAG-3/FGL-1 Signaling Pathway in Patients with Early-Onset Preeclampsia
por: Liang, Yue, et al.
Publicado: (2022)

The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer
por: Li, Jia-Jun, et al.
Publicado: (2023)

Hypersensitivity pneumonitis onset and severity is regulated by CD103 dendritic cell expression
por: Bernatchez, Emilie, et al.
Publicado: (2017)

A microfluidics-based method for isolation and visualization of cells based on receptor-ligand interactions
por: Dao, Long, et al.
Publicado: (2022)

FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer
por: Sun, Cuilan, et al.
Publicado: (2020)

Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu
por: Hou, Xin-Xin, et al.
Publicado: (2021)

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
por: Lv, Zheng, et al.
Publicado: (2021)

Pilicides inhibit the FGL chaperone/usher assisted biogenesis of the Dr fimbrial polyadhesin from uropathogenic Escherichia coli
por: Piatek, Rafał, et al.
Publicado: (2013)

Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer
por: Feng, Yanyan, et al.
Publicado: (2020)

Identification of the Receptor for FGL2 and Implications for Susceptibility to Mouse Hepatitis Virus (MHV-3)-Induced Fulminant Hepatitis
por: Liu, Hao, et al.
Publicado: (2006)

Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2
por: Fu, Yong, et al.
Publicado: (2020)

The Fgl2 interaction with Tyrobp promotes the proliferation of cutaneous squamous cell carcinoma by regulating ERK-dependent autophagy
por: Zeng, Mei, et al.
Publicado: (2022)

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis
por: Denicolò, Sara, et al.
Publicado: (2022)

sFgl2 gene-modified MSCs regulate the differentiation of CD4(+) T cells in the treatment of autoimmune hepatitis
por: Ji, Wenbin, et al.
Publicado: (2023)

Symphony No. 103/
por: Haydn, Joseph

Functional specialization of gut CD103(+) dendritic cells in the regulation of tissue-selective T cell homing
por: Johansson-Lindbom, Bengt, et al.
Publicado: (2005)

CD103(+) pulmonary dendritic cells preferentially acquire and present apoptotic cell–associated antigen
por: Desch, A. Nicole, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d4gm7fos5ffroqvq16fjhfrkea